cholestyramine resin has been researched along with diclofenac in 7 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (diclofenac) | Trials (diclofenac) | Recent Studies (post-2010) (diclofenac) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 8,874 | 1,874 | 3,616 |
| Protein | Taxonomy | cholestyramine resin (IC50) | diclofenac (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 1.9 | |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.003 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 1.3376 | |
| Interleukin-8 | Homo sapiens (human) | 0.008 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.0415 | |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | 0.5 | |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.012 | |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | 0.5 | |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | 0.5 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.4165 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.5 | |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | 0.5 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 1.6867 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.0502 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 4 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.5 | |
| P2Y purinoceptor 12 | Rattus norvegicus (Norway rat) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurowski, M; Menninger, H; Pauli, E | 1 |
| al-Balla, SR; al-Meshal, MA; el-Sayed, YM; Gouda, MW | 1 |
| Eggers, R; Farker, K; Haerting, J; Hoffmann, A; Madani, SF; Merkel, U; Müller, UA; Schweer, H; Seyberth, HW | 1 |
| Castañeda-Hernández, G; Jaimes-Hernández, J; Medina-Peñaloza, RM; Oropeza-De La Madrid, E; Robles-San Román, M; Rosas-Ramos, R; Suárez-Otero, R | 1 |
| Anders, S; Handel, M; Köck, FX; Phillips, O; Sell, S | 1 |
| Borges, BC; Borges, NC; Moreno, RA; Orpinelli, EZ; Pedrazzoli, J; Rigato, HM; Sverdloff, CE | 1 |
| Bendavit, GG; Cohen, JC; Geller, M; Higashi, R; Mibielli, MA; Nunes, CP; Oliveira, L; Scussel, AB | 1 |
7 trial(s) available for cholestyramine resin and diclofenac
| Article | Year |
|---|---|
The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients.
Topics: Absorption; Adult; Aged; Arthritis, Rheumatoid; Biological Availability; Cholestyramine Resin; Diclofenac; Double-Blind Method; Drug Combinations; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Pain Measurement; Tablets, Enteric-Coated | 1994 |
The effects of cholestyramine and colestipol on the absorption of diclofenac in man.
Topics: Absorption; Adsorption; Adult; Analysis of Variance; Blood Specimen Collection; Cholestyramine Resin; Chromatography, High Pressure Liquid; Colestipol; Diclofenac; Double-Blind Method; Drug Interactions; Humans; Male | 1994 |
Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cross-Over Studies; Diabetes Mellitus, Type 2; Diclofenac; Drug Combinations; Female; Glomerular Filtration Rate; Half-Life; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Prostaglandins; Renal Circulation | 2002 |
Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Celecoxib; Cholestyramine Resin; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Osteoarthritis; Pain Measurement; Pyrazoles; Sulfonamides | 2002 |
Dose-dependent efficacy of diclofenac-cholestyramine on pain and periarticular ossifications after total hip arthroplasty: a double-blind, prospective, randomised trial.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Cholestyramine Resin; Diclofenac; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Ossification, Heterotopic; Pain Measurement; Pain, Postoperative; Prospective Studies; Treatment Outcome | 2004 |
A simple high-performance liquid chromatographic method for the determination of diclofenac in human plasma: application to a comparative bioavailability study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biological Availability; Capsules; Cholestyramine Resin; Chromatography, High Pressure Liquid; Cross-Over Studies; Diclofenac; Drug Combinations; Female; Humans; Male; Reproducibility of Results; Therapeutic Equivalency; Young Adult | 2009 |
Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cytidine Monophosphate; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxocobalamin; Male; Middle Aged; Pain; Uridine Triphosphate | 2010 |